Combined Plasma DHA-Containing Phosphatidylcholine PCaa C38:6 and Tetradecanoyl-Carnitine as an Early Biomarker for Assessing the Mortality Risk among Sarcopenic Patients.

MLA

Ho, Hung-Yao, et al. “Combined Plasma DHA-Containing Phosphatidylcholine PCaa C38:6 and Tetradecanoyl-Carnitine as an Early Biomarker for Assessing the Mortality Risk among Sarcopenic Patients.” Nutrients, vol. 16, no. 5, Mar. 2024, p. 611. EBSCOhost, https://doi.org/10.3390/nu16050611.

APA

Ho, H.-Y., Chen, Y.-H., Lo, C.-J., Tang, H.-Y., Chang, S.-W., Fan, C.-M., Ho, Y.-H., Lin, G., Chiu, C.-Y., Lin, C.-M., & Cheng, M.-L. (2024). Combined Plasma DHA-Containing Phosphatidylcholine PCaa C38:6 and Tetradecanoyl-Carnitine as an Early Biomarker for Assessing the Mortality Risk among Sarcopenic Patients. Nutrients, 16(5), 611. https://doi.org/10.3390/nu16050611

Chicago

Ho, Hung-Yao, Yuan-Ho Chen, Chi-Jen Lo, Hsiang-Yu Tang, Su-Wei Chang, Chun-Ming Fan, Yu-Hsuan Ho, et al. 2024. “Combined Plasma DHA-Containing Phosphatidylcholine PCaa C38:6 and Tetradecanoyl-Carnitine as an Early Biomarker for Assessing the Mortality Risk among Sarcopenic Patients.” Nutrients 16 (5): 611. doi:10.3390/nu16050611.